Search Results - "SUISSA, Samy"
-
1
Guidelines for the Pharmacologic Treatment of COPD 2023: Canada versus GOLD
Published in Chronic obstructive pulmonary disease (01-12-2024)Get full text
Journal Article -
2
Immortal time bias in observational studies of drug effects
Published in Pharmacoepidemiology and drug safety (01-03-2007)“…Purpose Recent observational studies suggest that various drugs are remarkably effective at reducing morbidity and mortality. These cohort studies used a…”
Get full text
Journal Article -
3
Run-in bias in randomised trials: the case of COPD medications
Published in The European respiratory journal (01-06-2017)“…Most randomised trials of newer and established medications in chronic obstructive pulmonary disease (COPD) enrol patients who have already been treated, often…”
Get full text
Journal Article -
4
Sulfonylureas and the Risks of Cardiovascular Events and Death: A Methodological Meta-Regression Analysis of the Observational Studies
Published in Diabetes care (01-05-2017)“…Recent randomized trials have compared the newer antidiabetic agents to treatments involving sulfonylureas, drugs associated with increased cardiovascular…”
Get full text
Journal Article -
5
The effect of anti-acid therapy on survival in idiopathic pulmonary fibrosis: a methodological review of observational studies
Published in The European respiratory journal (01-06-2018)“…International treatment guidelines for idiopathic pulmonary fibrosis (IPF) give a conditional recommendation for anti-acid therapy. As some observational…”
Get full text
Journal Article -
6
Time‐related biases in pharmacoepidemiology
Published in Pharmacoepidemiology and drug safety (01-09-2020)“…Purpose Observational studies using computerized healthcare databases have become popular to investigate the potential effectiveness of old drugs for new…”
Get full text
Journal Article -
7
Triple therapy in COPD: understanding the data
Published in ERJ open research (01-01-2023)“…https://bit.ly/3tOgNdW…”
Get full text
Journal Article -
8
Triple therapy trials in COPD: a precision medicine opportunity
Published in The European respiratory journal (01-12-2018)Get full text
Journal Article -
9
Making Sense of Triple Inhaled Therapy for COPD
Published in The New England journal of medicine (03-05-2018)“…Guidelines for the treatment of chronic obstructive pulmonary disease (COPD) have consistently recommended long-acting inhaled bronchodilators — either…”
Get full text
Journal Article -
10
Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality
Published in Thorax (01-11-2012)“…The long-term natural history of chronic obstructive pulmonary disease (COPD) in terms of successive severe exacerbations and mortality is unknown. The authors…”
Get more information
Journal Article -
11
Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events
Published in The European respiratory journal (01-05-2017)“…The cardiovascular risk of concurrently using long-acting β -agonists (LABAs) and anticholinergics (LAMAs) in COPD is uncertain. We assessed the comparative…”
Get full text
Journal Article -
12
Comparative Effectiveness and Safety of LABA-LAMA vs LABA-ICS Treatment of COPD in Real-World Clinical Practice
Published in Chest (01-06-2019)“…Long-acting β2-agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) are recommended as initial maintenance treatments for COPD, with their…”
Get full text
Journal Article -
13
Inhaled corticosteroids in COPD: the clinical evidence
Published in The European respiratory journal (01-02-2015)“…In this article, we focus on the scientific evidence from randomised trials supporting treatment with inhaled corticosteroids (ICS) in chronic obstructive…”
Get full text
Journal Article -
14
Proton-pump inhibitors and increased gastric cancer risk: time-related biases
Published in Gut (01-12-2018)Get more information
Journal Article -
15
Incidence of and Mortality from Venous Thromboembolism in a Real-world Population: The Q-VTE Study Cohort
Published in The American journal of medicine (01-09-2013)“…Abstract Background The public health burden of venous thromboembolism, which includes deep vein thrombosis and pulmonary embolism, is not fully known, and…”
Get full text
Journal Article -
16
Cardiovascular disease and COPD: dangerous liaisons?
Published in European respiratory review (30-09-2018)“…Chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) frequently occur together and their coexistence is associated with worse outcomes…”
Get full text
Journal Article -
17
Discussion of Schuemie et al: “A plea to stop using the case‐control design in retrospective database studies”
Published in Statistics in medicine (30-09-2019)Get full text
Journal Article -
18
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study
Published in The lancet respiratory medicine (01-11-2018)“…Long-acting β2 agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) are the recommended initial maintenance treatment for chronic obstructive…”
Get full text
Journal Article -
19
Statins and Mortality in COPD: A Methodological Review of Observational Studies
Published in Chronic obstructive pulmonary disease (01-12-2023)“…Randomized controlled trials and observational studies have reported conflicting results on the potential beneficial effects of statins on mortality in…”
Get full text
Journal Article -
20
Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study
Published in BMJ (Online) (18-07-2018)“…AbstractObjectiveTo assess whether adding or switching to sulfonylureas is associated with an increased risk of myocardial infarction, ischaemic stroke,…”
Get full text
Journal Article